Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma

Clinical and Experimental Allergy

Volumn 30, Issue 1, 2000, Pages 64-70

  Yoshida, S ^a,b   Sakamoto, H ^a   Ishizaki, Y ^b   Onuma, K ^b   Shoji, T ^b   Nakagawa, H ^b   Hasegawa, H ^b   Nakabayashi, M ^b   Amayasu, H ^b,c  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AOKI International Medical Center   (Japan)

^c YOKOHAMA ROSAI HOSPITAL   (Japan)

Author keywords

Aspirin intolerant asthma; Bronchial hyperresponsiveness; Leukotriene; Pranlukast; Sulpyrine provocation test

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; DIPYRONE; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHACHOLINE; PEPTIDOLEUKOTRIENE; PLACEBO; PRANLUKAST;

ADULT; ALLERGIC ASTHMA; ARTICLE; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG MECHANISM; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANALGESICS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CHROMONES; CROSS-OVER STUDIES; DIPYRONE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED;

EID: 0033976821     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2000.00797.x     Document Type: Article

References (23)

1. 1 Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1975; 1:67-9.
2. 2 Lee TH. Mechanism of aspirin sensitivity. Am Rev Respir Dis 1992; 145:34-6.
3. 3 Houjou S, Dobashi K, Nakazawa T. Aspirin-induced asthma. Jpn J Clin Med 1994; 3:355-8.
4. 4 Power I. Aspirin-induced asthma. Br J Anaest 1993; 71:619-21.
5. 5 Szczeklik A, Schmitz SM. Aspirin-induced asthma: from pathogenesis to therapy. Allergol Immunopathol 1993; 21: 35-40.
6. 6 Szczeklik A, Sladak Dworski K et al. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1996; 154:1608-14.
7. 2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol 1996; 98:421-32.
8. 8 Szczeklik A. Aspirin-induced asthma as a viral disease. Clin Allergy 1988; 18:15-20.
9. 9 Obata T, Nanbu F, Kitagawa T et al. ONO-1078: an antagonist of leukotrienes. Adv Prostaglandin Thromboxane Leukot Res 1987; 17A:540-3.
10. 10 Fujimura M, Sakamoto S, Kanno Y, Matsuda T. Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma. Respir Med 1993; 87:133-8.
11. 11 Taki P, Suzuki R, Tori K, Matsumoto S, Takiguchi H, Takagi K. Reduction of the severity of bronchial hyperresponsiveness by the novel leukotriene antagonist 4-oxo-8-[4-(4-phenylbutoxy) benzoyl amino]-2-(tetrazol-5-yl) -4H-I-benzopyran hemihydrate. Drug Res 1994; 44:330-3.
12. 12 Taniguchi Y, Tamura G, Honma M et al. The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects. J Allergy Clin Immunol 1993; 92:507-12.
13. 13 Yamamoto H, Nagata M, Kuramitsu K et al. Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078. Am J Respir Crit Care Med 1994; 150:254-7.
14. 14 Cristie PE, Smith CM, Lee TH. The potent and selective sulfidopeptide leukotriene antagonist, SK & F 104353, inhibits aspirin-induced asthma. Am Rev Respir Dis 1991; 144:957-8.
15. 15 American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary diseases (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-44.
16. 16 Chai H, Farr RS, Froehlich LA et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56:323-7.
17. 4 excretion in aspirin-induced asthma. Ann Allergy Asthma Immunol 1998; 2:171-6.
18. 18 Makino S, Kobayashi S, Miyamoto T, Shida T, Takahashi S. Standard for allergen bronchial provocation tests in asthma and hypersensitivity pneumonitis. Jpn J Allerg 1982; 31:1074-6.
19. 4 during aspirin-induced asthma. J Lab Clin Med 1992; 119:48-51.
20. 20 Nasser SMS, Christie PE, Pfister R et al. Effect of endobronchial challenge on inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Thorax 1996; 51:64-70.
21. 21 Kobayashi S, Yoshida K, Mori A et al. Inhibitory effect of ONO-1078, a novel leukotriene receptor antagonist, on peripheral blood eosinophils. Jpn J Allergology 1996; 45:1166-71.
22. 22 Altounyan REC. Review of the clinical activity and modes of action of sodium cromoglycate. In: Pepys MB, Edwards JH, eds. The Mast Cell - Its Role in Health and Disease. London: Pitman Medical, 1979:199-216.
23. 23 Obata T, Okada Y, Motoishi M et al. In vitro antagonism of ONO-1078, a newly developed anti-asthma agent, against peptide leukotrienes in isolated guinea pig tissues. Jpn J Pharmacol 1992; 60:27-237.